Abstract: Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, pyrrole, and polyenoic acid derivatives including carbocyclic polyenoic acids. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.
Type:
Grant
Filed:
July 13, 1998
Date of Patent:
August 26, 2003
Assignee:
Ligand Pharmaceuticals, Inc.
Inventors:
Marcus F. Boehm, Richard A. Heyman, Lin Zhi, Chan Kou (Jack) Hwang, Steve White, Alex Nadzan
Abstract: Poly(3-cyclopropyl-3-hydroxypropionates) (I) which are useful for the preparation of vinylcyclopropane and cyclopropylacetylene are disclosed. Methods for the preparation of a variety of intermediates obtained from (I) such as 3-cyclopropyl-3-hydroxypropionic acid and esters and salts thereof, 3-cyclopropylacrylic acid, and vinylcyclopropane also are disclosed.
Type:
Grant
Filed:
April 11, 2000
Date of Patent:
August 26, 2003
Assignee:
Eastman Chemical Company
Inventors:
John Clark Hubbs, Theresa Sims Barnette, Neil Warren Boaz
Abstract: Process for the preparation of contrast agents The invention provides a process for the preparation of an N-alkyl-acylamino-phenyl-carboxylic acid or carboxylic acid derivative by liquid phase acylation and subsequent N-alkylation of a corresponding amino-phenyl-carboxylic acid (or carboxylic acid derivative), the improvement comprising the addition of an alkylating agent to a solution containing the reaction products of said acylation, to effect said N-alkylation.
Type:
Grant
Filed:
June 17, 1998
Date of Patent:
August 26, 2003
Assignee:
Amersham Health AS
Inventors:
Trygve Gulbrandsen, Odd Einar Ingvoldstad, Lars Terje Holmaas
Abstract: The present invention provides an efficient synthetic method of &agr;-ketol unsaturated fatty acid having a double bond at a &bgr;-position to the ketone group thereof. It comprises the steps of: preparing compound (4) by reacting monosubstituted acetylene (2) with epoxide (3); and preparing &agr;-ketol unsaturated fatty acid (1) from said compound (4) as shown in Reaction Formula 1:
wherein R1 represents an alkyl group of 1-18 carbon atoms or an aliphatic hydrocarbon group of 2-18 carbon atoms having 1-5 double or triple bonds at given positions; R2 represents a protecting group for a hydroxyl group; R3 represents a protecting group for a carboxyl group; R is identical to R1 or, when R1 has one or more triple bonds, represents an aliphatic hydrocarbon group in which each triple bond of R1 is converted to a double bond; and A represents an alkylene group of 1-18 carbon atoms.
Type:
Grant
Filed:
April 10, 2002
Date of Patent:
August 12, 2003
Assignee:
Shiseido Co., Ltd.
Inventors:
Yoshihiro Yokokawa, Koji Kobayashi, Shosuke Yamamura
Abstract: This invention provides a new class of squaraine dyes having moieties which serve for the covalent attachment to biological substrates and resulting in the fluorescent labeling of the substrates. The labeled substrates are intended for use in analytical techniques for the detection and measurement of biological and clinical compounds of interest.
Abstract: Enamide derivatives of formula (1) are described:
wherein
R1 is a group Ar1L2Ar2Alk- in which Ar1 is an optionally substituted aromatic or heteroaromatic group, L2 is a covalent bond or a linker atom or group, Ar2 is an optionally substituted arylene or heteroarylene group and Alk is a chain —CH2—CH(R)—, —CH═C(R)— or
in which R is a carboxylic acid (—CO2H) or a derivative or biostere thereof;
R2 is a hydrogen atom or a C1-6alkyl group;
X is an O or S atom or the group NR30 group;
j and k is each zero or the integer 1 or 2 provided that the sum of j and k is zero or the integer 1 or 2;
Cy1 is an optionally substituted cycloaliphatic, heterocycloaliphatic, aromatic or heteroaromatic group;
and the salts, solvates, hydrates and N-oxides thereof.
Type:
Grant
Filed:
September 5, 2001
Date of Patent:
August 5, 2003
Assignee:
Celltech R & D Limited
Inventors:
Timothy John Norman, John Robert Porter, John Clifford Head, Andrew James Ratcliffe
Abstract: Disclosed herein are compositions comprising organic anhydrides having a reduced tendency to discolor with time, even when held at elevated temperatures for extended times. The compositions are produced by mixing at least one acid halide and various derivatives of hydroxy carboxylic acids with an anhydride to form a homogenous solution. Also disclosed is a process for preparing the compositions.
Abstract: The invention relates to a method for producing a catalyst containing one or several metals from the group of metals comprising the sub-groups Ib and VIIIb of the periodic table on porous support particles, characterized by a first step in which one or several precursors from the group of compounds of metals from sub-groups Ib and VIIIb of the periodic table is or are applied to a porous support, and a second step in which the porous, preferably nanoporous support to which at least one precursor has been applied is treated with at least one reduction agent, to obtain the metal nanoparticles produced in situ in the pores of said support.
Type:
Grant
Filed:
April 28, 2000
Date of Patent:
August 5, 2003
Assignee:
Celanese Chemicals Europe GmbH
Inventors:
Alfred Hagemeyer, Uwe Dingerdissen, Klaus Kuhlein, Andreas Manz, Roland Fischer
Abstract: The invention provides a partially protected trisphenol having the general formula (I)
wherein R1 is an alkyl group of 1-4 carbons or an alkoxyl group of 1-4 carbons, R2 is an alkyl group of 1-6 carbons or a cycloalkyl group of 5 or 6 carbons, X1 is a hydrogen atom, an alkoxycarbonylmethyl group wherein the alkyl group has 1-4 carbons, an alkoxycarbonyl group wherein the alkyl group has 1-4 carbons or a tetrahydropyranyl group, X2 is a hydrogen atom, an alkoxycarbonylmethyl group wherein the alkyl group has 1-4 carbons, an alkoxycarbonyl group wherein the alkyl group has 1-4 carbons or a tetrahydropyranyl group, provided that when X1 is a hydrogen atom, X2 is not a hydrogen atom, and when X2 is a hydrogen atom, X1 is not a hydrogen atom; and m is an integer of 0, 1 or 2, and n is an integer of 0, 1, 2 or 3.
Abstract: This invention is in the area of methods and compositions for the inhibition of the expression of VCAM-1 and, in particular, for the treatment of diseases mediated by VCAM-1, including cardiovascular and inflammatory diseases.
Abstract: The invention relates to methods of modulating gene expression in a hematopoietic cell or augmenting hematopoiesis in a host, as well as methods of treating, preventing, or ameliorating disorders affecting hematopoiesis level in a host, by administering to the host or the hematopoietic cell an effective amount of a compound of formula (I).
Abstract: The present invention relates to novel antimycobacterial compounds and in particular to antimycobacterial compounds comprised of derivatives of phenyl 4-aminosalicylate. This invention further relates to methods for their preparation, to their use as therapeutic agents and to pharmaceutical compositions containing them. The novel methods of the invention yield derivatives of phenyl 4-aminosalicylate on a multi-gram scale and in high purity for subsequent biological evaluation in drug discovery.
Abstract: In industrial production of &ohgr;-hydroxyaliphatic acid being an important intermediate for large cyclic lactone-based perfumes, using dicarboxylate ester which is inexpensive and readily obtainable, a method, with high yield and improved selectively, for making a 2-(&ohgr;-alkoxycarbonylalkanoyl)-4-butanolide and an alkaline metal salt thereof, an ester of &ohgr;-hydroxy-(&ohgr;-3)-ketoaliphatic acid as a novel compound and a derivative thereof, and a method for making the same are provided.
Abstract: The present invention provides compounds that are effective in treating disorders caused by the enzymatic activity of matrix metalloproteinases. These disorders include, but are not limited to, rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis, corneal ulceration, and in complications of diabetes. The present invention is also is useful for treating wounds.
Abstract: The invention relates to method for the enhancement of the activity and/or systemicity of fungicidal compositions containing at least one benzoylbenzene of formula I
wherein
R1 through R7, m and n are as defined in claim 1,
with the aid of one or more adjuvants selected from the group consisting of
(a) alkylpolyglycosides, alkenyl succinic acid derivatives, dialkyl sulfosuccinates, polyvinylpyrrolidones, perfluoroalkyl acids derivatives, perfluoro(C3-20)alkyl esters of carboxylic acids, and mixtures thereof;
(b) alkoxylated alcohols, amines or acids;
(c) water-immiscible polar aprotic solvents;
and to the use of such a composition as a fungicide.
Abstract: The compounds of the instant invention are bicyclic or tricyclic amino acids useful in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, arthritis, neuropathological disorders, sleep disorders, visceral pain disorders, and gastrointestinal disorders. Processes for the preparation of the final products and intermediates useful in the process are included. Pharmaceutical compositions containing one or more of the compounds are also included.
Type:
Grant
Filed:
April 16, 2002
Date of Patent:
July 22, 2003
Assignee:
Pfizer Inc
Inventors:
David Clive Blakemore, Justin Stephen Bryans, Sophie Caroline Williams
Abstract: 3,4-Disubstituted-1-cyclopentene compounds, in substantially enantiopure form, have the relative stereochemistry according to formula (1A) or (1B)
including the opposite enantiomers thereof, wherein
R1 is either
COOX, wherein X is selected from the group consisting of alkyl, H, and a salt-forming cation, or
CH2OH, whererin the hydroxy group is optionally protected;
R2 is H or a protecting group;
R3 is H or alkyl, and
R4 is selected from the group consisting of H, alkoxy, alkyl, aryl, and aralkyl; or, in the case of formula (1A), R2 and R4 are linked to form an oxazolidonone ring.
These compounds can be used to prepare a series of complementary stereochemcially varied cyclopentane scaffolds.
Type:
Grant
Filed:
September 11, 2000
Date of Patent:
July 15, 2003
Assignee:
ChirotechTechnology Limited
Inventors:
Mark Edward Brennan Smith, Nadine Derrien
Abstract: O-medium alkyl esters of diflunisal and related compounds are disclosed having anti-platelet activity, hydroxy radical scavenging properties, enhanced hepatic clearance and low ulcerogenic potential. These compounds have general formula (I) wherein n equals 3-13.
Type:
Grant
Filed:
October 12, 1999
Date of Patent:
July 15, 2003
Assignee:
The University of Queensland
Inventors:
Daniel Yung-Yu Hung, Michael Stephen Roberts
Abstract: The present invention provides a novel class of RXR modulator compounds that exhibit an improved pharmacologic profile relative to the profile of previously studied RXR modulators, including those that share common structural features with the presently claimed modulators. The present invention also provides synthetic methods for preparing these compounds as well as pharmaceutical compositions incorporating these novel compounds and methods for the therapeutic use of such compounds and pharmaceutical compositions.
Type:
Grant
Filed:
September 14, 2000
Date of Patent:
July 15, 2003
Assignee:
Ligand Pharmaceuticals, Inc.
Inventors:
Robert J. Ardecky, Marcus F. Boehm, Amy L. Faulkner, Lawrence G. Hamann, Todd K. Jones, Christopher M. Mapes, Pierre-Yves Michellys, John S. Tyhonas, Anthony W. Thompson, Jyun-Hung Chen